Addex Therapeutics Ltd’s CHF 40 million capital increase

Allosteric modulation company Addex Therapeutics Ltd announced that it has launched a CHF 40 m capital increase with commitments in place from several world-leading healthcare investors,…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

This content is for Standard 1 Year members only.
Login Join Now